Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Tofacitinib may help regrow hair in alopecia areata patients.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Testosterone undecanoate safely and effectively increased penis size in male children with 5-alpha-reductase deficiency.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

A woman's hair turned white after taking a cancer drug called dasatinib.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Denosumab may cause alopecia areata.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Strontium ranelate is no longer available for treatment.

Dutasteride is more effective than finasteride for hair growth in men, with similar safety.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.